Antheia: Funding, Investors & Team (Sep 2026)
Antheia focuses on creating biosynthetic key starting materials (KSMs) and active pharmaceutical ingredients (APIs) for important medications through synthetic biology. By manipulating yeast to recreate intricate biosynthetic pathways, the company transforms basic sugars into pharmaceutical substances using fermentation. This method is designed to lessen the need for traditional farming sources and chemical production, providing a more dependable supply chain. Antheia's range of products includes compounds for medical fields like neurology, oncology, and gastroenterology. The company assists pharmaceutical collaborators from initial development to regulatory approval to promote the use of biomanufactured ingredients.
Antheia has raised $132M across 4 funding rounds on record, the most recent a Series C of $24.0M announced in Jan 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Antheia Company Profile and Key Stats
Latest funding round on record: Jan 2026.
Antheia Funding Rounds
Antheia raised $40.0M in a Debt Financing announced in Jun 2022.
2.5 years later, an undisclosed round of $12.0M was announced in Dec 2024.
6 months later, a Series C of $56.0M was announced in Jun 2025.
7 months later, a Series C of $24.0M was announced in Jan 2026.
Antheia Founders and Leadership Team
Contact details for the Antheia team: 2 of 2 have an email address on file.
Start 14-day free trial →Antheia Funding Compared to Other Biotechnology Startups
Antheia's latest round of $24.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Antheia in Biotechnology and Menlo Park
Companies Similar to Antheia
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Antheia Funding FAQs
What does Antheia do?
Antheia focuses on creating biosynthetic key starting materials (KSMs) and active pharmaceutical ingredients (APIs) for important medications through synthetic biology. By manipulating yeast to recreate intricate biosynthetic pathways, the company transforms basic sugars into pharmaceutical substances using fermentation. This method is designed to lessen the need for traditional farming sources and chemical production, providing a more dependable supply chain. Antheia's range of products includes compounds for medical fields like neurology, oncology, and gastroenterology. The company assists pharmaceutical collaborators from initial development to regulatory approval to promote the use of biomanufactured ingredients.
How much funding has Antheia raised?
Antheia has raised $132M across 4 rounds on record. The most recent is a Series C of $24.0M announced in Jan 2026.
When did Antheia last raise funding?
Antheia's most recent funding round on record is a Series C of $24.0M, announced in Jan 2026.
Who founded Antheia?
FundedIQ lists Christina Smolke (Founder), Kristy Hawkins (Founder) at Antheia.
Where is Antheia headquartered?
Antheia is based in Menlo Park, California, United States.
How many employees does Antheia have?
Antheia is in the 51-100 employee band.
How does Antheia's funding compare to other Biotechnology startups?
Antheia's latest round of $24.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Antheia Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Antheia is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.